Synergy Pharma (SGYP) Tops Q3 EPS by 5c

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/9/2026

1. HUM
2. SPCX
3. ALHC
4. T
5. PEP
6. CVS
7. UNH
8. AXP
9. ZETA
10. DAL

Go back to Synergy Pharma (SGYP) Tops Q3 EPS by 5c

Synergy Pharmaceuticals Reports Third Quarter 2015 Financial Results and Business Update

November 9, 2015 8:00 AM EST

NEW YORK--(BUSINESS WIRE)-- Synergy Pharmaceuticals Inc. (NASDAQ: SGYP), a biopharmaceutical company focused on the development and commercialization of novel gastrointestinal (GI) therapies, today reported its financial results and business update for the three and nine months ended September 30, 2015.

The Synergy team continues to successfully execute on our key pipeline and corporate objectives, said Gary S. Jacob, Chairman and CEO of Synergy. Our strong year-to-date performance has resulted in a significant increase in value for our shareholders, enabling us to strengthen our balance sheet and financial position by reducing our debt by... More